financetom
Business
financetom
/
Business
/
Cars.com Insider Sold Shares Worth $368,137, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cars.com Insider Sold Shares Worth $368,137, According to a Recent SEC Filing
May 28, 2024 3:29 PM

06:01 PM EDT, 05/28/2024 (MT Newswires) -- Angelique Strong Marks, Chief Legal Officer, on May 23, 2024, sold 19,835 shares in Cars.com ( CARS ) for $368,137. Following the Form 4 filing with the SEC, Marks has control over a total of 101,928 shares of the company, with 101,928 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1683606/000095017024065449/xslF345X03/ownership.xml

Price: 19.24, Change: -0.09, Percent Change: -0.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sernova Biotherapeutics Provides
Sernova Biotherapeutics Provides "Positive" Interim Data From Type 1 Diabetes Cell Pouch Trial
May 26, 2025
08:33 AM EDT, 05/14/2025 (MT Newswires) -- Sernova Biotherapeutics ( SEOVF ) on Wednesday said interim data from its ongoing Phase 1/2 clinical trial in patients with type 1 diabetes (T1D) show a majority of the enrolled patients achieving insulin independence and improved blood sugar control. The clinical trial involved transplanting Sernova's cell pouch with human donor cells or stem-cell...
BioCryst Pharmaceuticals Says FDA Grants Priority Review for Orladeyo in Children
BioCryst Pharmaceuticals Says FDA Grants Priority Review for Orladeyo in Children
May 26, 2025
08:33 AM EDT, 05/14/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Wednesday that the US Food and Drug Administration has accepted and granted priority review to its new drug application for Orladeyo, or berotralstat, to treat hereditary angioedema in children 2 to 11 years old. The company said the FDA has set a target action date of Sept....
Aeva Technologies Enters Collaboration, Investment Agreement With Fortune 500 Company
Aeva Technologies Enters Collaboration, Investment Agreement With Fortune 500 Company
May 26, 2025
08:32 AM EDT, 05/14/2025 (MT Newswires) -- Aeva Technologies ( AEVA ) said Wednesday it has entered into a strategic collaboration with an affiliate of a Fortune 500 company to bring its 4D light detection and ranging technology into new industrial and consumer markets. The company will invest up to around $50 million to bring production capacity online for Aeva's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved